Home NDC 61715-090 Acid Reducer
Product NDC 61715-090
11-digit product format 617150090
Labeler code 61715
Product ID 61715-090_6ac37537-b020-4981-92ec-825f72a0268c
Type HUMAN OTC DRUG
Nonproprietary name Ranitidine
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Preferred Plus (Kinray)
Application ANDA201745
Marketing category ANDA
Marketing start 2014-01-27
Marketing end 0000-00-00
Substance RANITIDINE HYDROCHLORIDE
Active strength 75 mg/1
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61715-090-30 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61715-090-30 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61715-090-30 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61715-090-30 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61715-090-30 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61715-090-30 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61715-090-30 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61715-090-30 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 61715-090-30 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 61715-090-30 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 61715-090-30 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 61715-090-30 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 61715-090-30 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 61715-090-30 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 61715-090-30 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 61715-090-30 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 61715-090-30 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 61715-090-30 I Inactivated by FDA bd6a592717d7…303034d00443…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A201745-001 RANITIDINE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A201745-001 RANITIDINE HYDROCHLORIDE EQ 75MG BASE TABLET / ORAL 2012-02-29 e64feba35796…
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RANITIDINE HYDROCHLORIDE ACTIVE INGREDIENT BK76465IHM ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 RANITIDINE ACTIVE MOIETY 884KT10YB7 ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 HYPROMELLOSES INACTIVE INGREDIENT 3NXW29V3WO ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 TALC INACTIVE INGREDIENT 7SEV7J4R1U ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ACID REDUCER (RANITIDINE ) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61715-090 ACID REDUCER (RANITIDINE) TABLET, FILM COATED [PREFERRED PLUS (KINRAY)] 2 Legacy NDC 20200115_00a6fe2f-d9e6-4d75-9c21-16b40b1da320.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 61715-090-30 61715009030 3 BLISTER PACK in 1 CARTON (61715-090-30) > 10 TABLET, FILM COATED in 1 BLISTER PACK 3 blister pack 2020-01-15 0000-00-00 No No Current